Showing results (1711-1720 of 1,770) with videos related to

Sort By:
Pageof 177
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-Acetyl-pyridinium bromanilateLynne H Thomas, Bryan Boyle, Lesley A Clive, et al.
Translational Psychiatry|April 13, 2021
HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestryBettina Konte, James T R Walters, Dan Rujescu, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 8, 2016
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant responseChiara Fabbri, Ladislav Hosak, Rainald Mössner, et al.
Journal of Psychiatric Research|May 17, 2014
The role of leptin, melanocortin, and neurotrophin system genes on body weight in anorexia nervosa and bulimia nervosaZeynep Yilmaz, Allan S Kaplan, Arun K Tiwari, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 5, 2022
Recommendations to encourage participation of individuals from diverse backgrounds in psychiatric genetic studiesCasey MacDermod, Michaela A Pettie, Emily A Carrino, et al.
Clinical Pharmacology and Therapeutics|January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 StudyLeen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
Pageof 177